According to a new study published in the Journal of the American College of Cardiology, women with preeclampsia with severe features (PEC) have higher right ventricular (RV) systolic pressure (RVSP) and decreased global right ventricular longitudinal systolic strain (RVLSS), among other adverse cardiovascular events, compared to women not exhibiting preeclampsia during pregnancy.

Sleep disturbances, including poor sleep quality and insomnia, are associated with increased blood pressure and vascular inflammation in women, according to a June 9 study in the Journal of the American Heart Association.

A new study published in Hypertension suggests tailoring blood pressure (BP) treatment to a patient’s exercise level may help, because people with elevated but controlled hypertension saw an increase in BP during physical activity.

Frequent binge drinkers—particularly men—are more likely to have cardiovascular risk factors such as hypertension and high cholesterol, according to a new study published in the Journal of the American Heart Association.

The FDA announced on June 21 it has approved the Eversense Continuous Glucose Monitoring (CGM) system, the first fully implantable product of its kind. The device can be worn for up to 90 days, whereas most CGMs are replaced every week or two.

On Monday, June 18, the U.S. Food and Drug Administration (FDA) officially banned the use of trans fats, or partially hydrogenated oils (PHOs), in all foods sold in American restaurants and grocery stores.

Work stress is six times more likely to kill men than women who exhibit cardiometabolic disease despite otherwise being healthy, according to a new study published June 5 in The Lancet: Diabetes & Endocrinology.

A single blood sample to test both fasting glucose and hemoglobin A1c (HbA1c) may be sufficient to identify people with undiagnosed type 2 diabetes, according to a study published June 19 in the Annals of Internal Medicine.